UROGRAFIN

This brand name is authorized in Estonia, Ireland, Japan, Lithuania, New Zealand, Spain.

Active ingredients

The drug UROGRAFIN contains one active pharmaceutical ingredient (API):

1
UNII 5UVC90J1LK - DIATRIZOIC ACID
 
Read more about Diatrizoic acid

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 UROGRAFIN Solution for infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V08AA01 Diatrizoic acid V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media
Discover more medicines within V08AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1079412
ES Centro de información online de medicamentos de la AEMPS 23817
JP 医薬品医療機器総合機構 7214400A2034, 7214400A5041, 7214400A6030
LT Valstybinė vaistų kontrolės tarnyba 1010502, 1010503, 1031777, 1091061
NZ Medicines and Medical Devices Safety Authority 711, 712

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈